Business Context and Reporting Period
This Form 6-K filing by Euronav NV (Euronav) covers the month of December 2017. The primary purpose of the filing is to disclose the entry into a definitive Agreement and Plan of Merger with Gener8 Maritime Inc. (Gener8), dated December 20, 2017. Euronav is an independent tanker company headquartered in Antwerp, Belgium, operating a fleet of 53 vessels. Gener8 is a Marshall Islands-incorporated tanker company with a fleet of 30 vessels.
Key Financial Metrics and Transaction Terms
The filing focuses on the structural and financial terms of the proposed merger rather than historical operating results for the period.
- Exchange Ratio: Gener8 shareholders will receive 0.7272 shares of Euronav ordinary shares for each share of Gener8 common stock.
- Share Issuance: The transaction is expected to result in the issuance of approximately 60.9 million new Euronav ordinary shares.
- Ownership Structure: Post-merger, Euronav shareholders are expected to own approximately 72% of the Combined Entity, while Gener8 shareholders will own approximately 28%.
- Asset Acquisition: Euronav will acquire Gener8's 30 operating crude tanker vessels (21 VLCCs, 6 Suezmax, 1 Aframax, 2 Panamax) with an aggregate capacity of 8.1 million deadweight tons (dwt) and a weighted average age of 3.7 years.
- Termination Fee: Under specific circumstances, Euronav is entitled to a termination fee of $39 million from Gener8.
- Contingent Vessel Purchase: If the merger is not consummated, Euronav has executed memoranda of agreement to purchase three specific Gener8 vessels for a total price of $220.9 million.
- Debt Assumption: Euronav will assume Gener8's indebtedness under two loan agreements, subject to lender consents. Gener8's outstanding notes are expected to be repaid prior to or contemporaneously with the merger.
Material Changes and Related Agreements
The filing details significant strategic changes contingent upon the merger's completion:
- Board Composition: Euronav will increase its Board size by one, appointing Mr. Steve Smith, a former Gener8 director, as an independent director.
- Shareholder Support: A group of shareholders representing approximately 48% of Gener8's issued shares has committed to vote in favor of the transaction via a Shareholder Support and Voting Agreement.
- Asset Divestiture: Subject to the merger's consummation, an unaffiliated third party has agreed to purchase six VLCC vessels from the Combined Entity for an aggregate price of $434 million at closing.
- Management Continuity: Euronav's current board and executive management will continue to serve in the Combined Company.
Guidance, Outlook, Risks, and Contingencies
The filing contains extensive forward-looking statements regarding the merger's benefits and risks. Key contingencies and risks include:
- Closing Conditions: The merger is subject to Gener8 shareholder approval, SEC effectiveness of a Form F-4 registration statement, NYSE listing approval, and receipt of lender consents.
- Termination Rights: The agreement includes a "drop-dead" date of June 30, 2018, extendable to July 31, 2018, under certain conditions.
- Integration Risks: Risks include the failure to realize anticipated synergies, inability to integrate operations successfully, and retention of key personnel.
- Market and Regulatory Risks: Factors include changes in trade policies, tax laws, regulatory changes in the seaborne transportation industry, and general economic conditions.
- Financial Uncertainty: The filing explicitly states that the Merger Agreement should not be relied upon as a characterization of the actual state of facts, as representations are qualified by confidential disclosure schedules.
Important Facts for Investor Verification
- Verify the final outcome of the Gener8 shareholder vote required to approve the merger.
- Confirm the receipt of all necessary lender consents for the assumption of Gener8's loan agreements.
- Monitor the SEC's declaration of effectiveness for the Form F-4 registration statement.
- Review the definitive proxy statement/prospectus (Form F-4) for detailed financial data and risk factors not fully elaborated in this summary.
- Track the status of the $434 million sale of six VLCC vessels to a third party, which is contingent on the merger closing.